Alexander R. Menter, MD, oncologist, Kaiser Permanente, discusses the use of neoadjuvant immunotherapy in patients with early-stage non–small cell lung cancer (NSCLC).
Alexander R. Menter, MD
Advertisement
Articles by Alexander R. Menter, MD
Advertisement
Latest Updated Articles
Dr. Menter on Neoadjuvant Immunotherapy in Early-Stage NSCLCAugust 9th 2018
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
3
Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC
4
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
5